University of Miami Clinical Research Unit of the Diabetic Foot Consortium
University of Miami Clinical Research Unit of the Diabetic Foot Consortium
批准号:
10214223
负责人:
Robert Scott Kirsner
金额:
$10.92万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-15 至 2022-06-30
关键词:
AddressAreaBiocompatible MaterialsBiologicalBiological MarkersBloodBlood VesselsCaringCellsCenter for Translational Science ActivitiesClinicalClinical DataClinical InvestigatorClinical ResearchClinical TrialsCollaborationsComplexComplications of Diabetes MellitusDataData AnalysesData CollectionDatabasesDebridementDermatologyDiabetic FootDiabetic Foot UlcerEmergency department visitEnvironmentEpidermisFoot UlcerFunctional disorderFutureGoalsHealthHome environmentImageImpaired healingIncidenceIndividualInfectionInfrastructureInterventionKnowledgeLiquid substanceLower ExtremityMeasurementMonitorMulti-Institutional Clinical TrialNational Institute of Diabetes and Digestive and Kidney DiseasesNeuropathyNon-Insulin-Dependent Diabetes MellitusNuclearOcclusive DressingsOffice VisitsOperative Surgical ProceduresOsteomyelitisOutcomeOutpatientsPatient RecruitmentsPatientsPersonsPodiatryPopulationPositioning AttributeProtocols documentationPublicationsQuality ControlRecording of previous eventsResearchResearch DesignResearch PersonnelResourcesRiskSafetyScientistSerumShipsSiteSkin graftStructureSubgroupSwabSystemTestingTissue AdhesivesTissue SampleTissuesTranslational ResearchTranslational trialUlcerUnited States National Institutes of HealthUniversitiesUrineVaricose UlcerVascular DiseasesWorkbasebeta cateninc-myc Geneschronic woundclinical diagnosticsclinical practiceclinical research sitecostevidence baseexperiencefollow-uphealingimprovedimproved outcomeinnovationmortalitymultidisciplinarynovel therapeutic interventionnovel therapeuticspotential biomarkerprogramsprospectiverecruitresearch studyresponsesecondary infectionstandard caresuccesssupportive environmenttooltreatment optimizationwoundwound healing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
In response to RFA-DK-17-014, we propose the University of Miami Clinical Research Unit (UM-CRU) as a
site for the NIH Diabetic Foot Consortium (DFC) for future clinical study of selected biomarkers. The objective
of UM-CRU is to establish the organizational framework and infrastructure that will serve as a platform for
integrated multidisciplinary experimental clinical and translational research focusing on patients with diabetic
foot ulcers (DFU). The UM-CRU will, in conjunction with DFC develop the research design and study protocol,
and establish protocols for participant recruitment and follow-up, data collection, quality control, interim data
and safety monitoring, final data analysis and interpretation, and publication of results. Furthermore, UM-CRU
will facilitate procurement, storage and shipment of the biomaterials (tissue samples, swabs, wound fluid,
blood, serum and/or urine) as a part of the future biomarker studies. In addition, UM-CRU will establish and
maintain clinical data base that will allow overall data analyses of the DFC. The wound healing clinical
research team at the University of Miami has established a successful, decades-long track record of
conducting single- and multi-center clinical and translational trials for DFU and other types of chronic wounds.
Thus, UM-CRU provides unique expertise and infrastructure that can provide a platform for multi-center data
(clinical and biological) analyses. The overall structure of UM-CRU includes establishing an Administrative
Core to coordinate all aspects of the UM-CRU activities, regulatory clinical team, clinical investigator team and
translational research unit. The long-term goal of the UM-CRU is to provide a platform for innovation leading
to new therapeutic approaches and discoveries focusing on patients with DFU. The combination of
established outstanding group of clinicians and scientists, research tools, existing resources, capabilities,
supportive environment and collaborative expertise at UM represents a unique environment to greatly
advance the field of DFU related research. UM-CRU will provide outstanding clinical research base for all
proposed activities of the DFC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing strategies for effective debridement in patients for venous leg ulcers
-
批准号:10311083
-
项目类别:
-
资助金额:$53.47万
-
财政年份:2018
-
负责人:Robert Scott Kirsner
-
依托单位:
Developing strategies for effective debridement in patients for venous leg ulcers
-
批准号:10531195
-
项目类别:
-
资助金额:$47.25万
-
财政年份:2018
-
负责人:Robert Scott Kirsner
-
依托单位:
Developing strategies for effective debridement in patients for venous leg ulcers
-
批准号:9772256
-
项目类别:
-
资助金额:$53.06万
-
财政年份:2018
-
负责人:Robert Scott Kirsner
-
依托单位:
SunSmart America: Evaluating a School-based Curriculum
-
批准号:7498375
-
项目类别:
-
资助金额:$30.07万
-
财政年份:2004
-
负责人:Robert Scott Kirsner
-
依托单位:
SunSmart America: Evaluating a School-based Curriculum
-
批准号:7122878
-
项目类别:
-
资助金额:$30.35万
-
财政年份:2004
-
负责人:Robert Scott Kirsner
-
依托单位:
SunSmart America: Evaluating a School-based Curriculum
-
批准号:6816268
-
项目类别:
-
资助金额:$30.31万
-
财政年份:2004
-
负责人:Robert Scott Kirsner
-
依托单位:
SunSmart America: Evaluating a School-based Curriculum
-
批准号:6948592
-
项目类别:
-
资助金额:$30.18万
-
财政年份:2004
-
负责人:Robert Scott Kirsner
-
依托单位:
SunSmart America: Evaluating a School-based Curriculum
-
批准号:7292691
-
项目类别:
-
资助金额:$29.33万
-
财政年份:2004
-
负责人:Robert Scott Kirsner
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: